These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20436300)

  • 61. Growth inhibitory effect and Chk1-dependent signaling involved in G2/M arrest on human gastric cancer cells induced by diallyl disulfide.
    Ling H; Wen L; Ji XX; Tang YL; He J; Tan H; Xia H; Zhou JG; Su Q
    Braz J Med Biol Res; 2010 Mar; 43(3):271-8. PubMed ID: 20401435
    [TBL] [Abstract][Full Text] [Related]  

  • 62. New partners for Chk1.
    Iliakis G
    Cell Cycle; 2010 Jun; 9(11):2061-2. PubMed ID: 20559029
    [No Abstract]   [Full Text] [Related]  

  • 63. Adaptation to the ionizing radiation-induced G2 checkpoint occurs in human cells and depends on checkpoint kinase 1 and Polo-like kinase 1 kinases.
    Syljuåsen RG; Jensen S; Bartek J; Lukas J
    Cancer Res; 2006 Nov; 66(21):10253-7. PubMed ID: 17079442
    [TBL] [Abstract][Full Text] [Related]  

  • 64. CHK1 and CHK2 are differentially involved in mismatch repair-mediated 6-thioguanine-induced cell cycle checkpoint responses.
    Yan T; Desai AB; Jacobberger JW; Sramkoski RM; Loh T; Kinsella TJ
    Mol Cancer Ther; 2004 Sep; 3(9):1147-57. PubMed ID: 15367709
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Characterization of a Saccharomyces cerevisiae homologue of Schizosaccharomyces pombe Chk1 involved in DNA-damage-induced M-phase arrest.
    Liu Y; Vidanes G; Lin YC; Mori S; Siede W
    Mol Gen Genet; 2000 Jan; 262(6):1132-46. PubMed ID: 10660074
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Inhibition of cell death and induction of G2 arrest accumulation in human ovarian clear cells by HNF-1β transcription factor: chemosensitivity is regulated by checkpoint kinase CHK1.
    Shigetomi H; Sudo T; Shimada K; Uekuri C; Tsuji Y; Kanayama S; Naruse K; Yamada Y; Konishi N; Kobayashi H
    Int J Gynecol Cancer; 2014 Jun; 24(5):838-43. PubMed ID: 24804869
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Fhit and CHK1 have opposing effects on homologous recombination repair.
    Hu B; Wang H; Wang X; Lu HR; Huang C; Powell SN; Huebner K; Wang Y
    Cancer Res; 2005 Oct; 65(19):8613-6. PubMed ID: 16204026
    [TBL] [Abstract][Full Text] [Related]  

  • 68. BRCA1-mediated G2/M cell cycle arrest requires ERK1/2 kinase activation.
    Yan Y; Spieker RS; Kim M; Stoeger SM; Cowan KH
    Oncogene; 2005 May; 24(20):3285-96. PubMed ID: 15735702
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mismatch repair-mediated G2/M arrest by 6-thioguanine involves the ATR-Chk1 pathway.
    Yamane K; Taylor K; Kinsella TJ
    Biochem Biophys Res Commun; 2004 May; 318(1):297-302. PubMed ID: 15110787
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Chk1, but not Chk2, is involved in the cellular response to DNA damaging agents: differential activity in cells expressing or not p53.
    Carrassa L; Broggini M; Erba E; Damia G
    Cell Cycle; 2004 Sep; 3(9):1177-81. PubMed ID: 15326376
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Jaridonin-induced G2/M phase arrest in human esophageal cancer cells is caused by reactive oxygen species-dependent Cdc2-tyr15 phosphorylation via ATM-Chk1/2-Cdc25C pathway.
    Ma YC; Su N; Shi XJ; Zhao W; Ke Y; Zi X; Zhao NM; Qin YH; Zhao HW; Liu HM
    Toxicol Appl Pharmacol; 2015 Jan; 282(2):227-36. PubMed ID: 25450480
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Increasing cisplatin sensitivity by schedule-dependent inhibition of AKT and Chk1.
    Duan L; Perez RE; Hansen M; Gitelis S; Maki CG
    Cancer Biol Ther; 2014; 15(12):1600-12. PubMed ID: 25482935
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Involvement of the role of Chk1 in lithium-induced G2/M phase cell cycle arrest in hepatocellular carcinoma cells.
    Wang XM; Li J; Feng XC; Wang Q; Guan DY; Shen ZH
    J Cell Biochem; 2008 Jul; 104(4):1181-91. PubMed ID: 18247328
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint.
    Liu Q; Guntuku S; Cui XS; Matsuoka S; Cortez D; Tamai K; Luo G; Carattini-Rivera S; DeMayo F; Bradley A; Donehower LA; Elledge SJ
    Genes Dev; 2000 Jun; 14(12):1448-59. PubMed ID: 10859164
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Insulin-like growth factor I receptor regulates the radiation-induced G2/M checkpoint in HeLa cells.
    Manila NG; Kaida A; Nakahama KI; Miura M
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2977-2983. PubMed ID: 30119887
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Regulation of mitosis in response to damaged or incompletely replicated DNA require different levels of Grapes (Drosophila Chk1).
    Purdy A; Uyetake L; Cordeiro MG; Su TT
    J Cell Sci; 2005 Aug; 118(Pt 15):3305-15. PubMed ID: 16079276
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Human Chk1 expression is dispensable for somatic cell death and critical for sustaining G2 DNA damage checkpoint.
    Chen Z; Xiao Z; Chen J; Ng SC; Sowin T; Sham H; Rosenberg S; Fesik S; Zhang H
    Mol Cancer Ther; 2003 Jun; 2(6):543-8. PubMed ID: 12813133
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Induction of DNA damage and G2 cell cycle arrest by diepoxybutane through the activation of the Chk1-dependent pathway in mouse germ cells.
    Dong J; Wang Z; Zou P; Zhang G; Dong X; Ling X; Zhang X; Liu J; Ye D; Cao J; Ao L
    Chem Res Toxicol; 2015 Mar; 28(3):518-31. PubMed ID: 25633853
    [TBL] [Abstract][Full Text] [Related]  

  • 79. CHK1-regulated S-phase checkpoint response reduces camptothecin cytotoxicity.
    Wang JL; Wang X; Wang H; Iliakis G; Wang Y
    Cell Cycle; 2002; 1(4):267-72. PubMed ID: 12429946
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP.
    Martin A; David V; Laurence JS; Schwarz PM; Lafer EM; Hedge AM; Rowe PS
    Endocrinology; 2008 Apr; 149(4):1757-72. PubMed ID: 18162525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.